Overview of event
As the global leader in safeguarding high-value R&D sample assets, Astoriom will be participating in the ESGCT 2025 Annual Congress to connect with gene and cell therapy researchers, biotechs, and translational science leaders shaping the future of advanced therapies. These therapies depend on the integrity of irreplaceable samples—whether viral vectors, engineered cell lines, or clinical trial materials—requiring robust infrastructure to preserve viability and ensure regulatory readiness.
At ESGCT, we’ll be showcasing our end-to-end biorepository and stability storage services, built to meet the stringent demands of CGT developers across all temperature ranges, from -80°C to vapour-phase liquid nitrogen (-196°C). Astoriom’s expertise in disaster recovery, chain of custody, and validated storage solutions makes us a critical partner for any organisation looking to protect therapeutic innovation through every phase of development.
Meet us at Booth D38
